Evidence map›Paper›PMID 41831272›Full record

ArticleDNA repair2026

B cell receptor stimulation inhibits class switch recombination through elevated DNA repair.

Robert W Maul, Rhonda L McFleder, Zheng Cao, Darrell D Norton, Jana Ridani, Philip Barbulescu, Alberto Martin, Javier M Di Noia, Patricia J Gearhart

Abstract read
In one paragraph

Article in DNA repair, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Robert W MaulLaboratory of Molecular Biology and Immunology, National Institute on Aging, NIH, Baltimore, MD 21224 USA.
Rhonda L McFlederLaboratory of Molecular Biology and Immunology, National Institute on Aging, NIH, Baltimore, MD 21224 USA.
Zheng CaoLaboratory of Molecular Biology and Immunology, National Institute on Aging, NIH, Baltimore, MD 21224 USA.
Darrell D NortonLaboratory of Molecular Biology and Immunology, National Institute on Aging, NIH, Baltimore, MD 21224 USA.
Jana RidaniInstitut de Recherches Cliniques de Montréal, Montréal, Québec H2W 1R7, Canada; Department of Medicine, Division of Experimental Medicine, McGill University, Montreal, Québec H4A 3J1, Canada.
Philip BarbulescuDepartment of Immunology, University of Toronto, Toronto, ON, Canada.
Alberto MartinDepartment of Immunology, University of Toronto, Toronto, ON, Canada.
Javier M Di NoiaInstitut de Recherches Cliniques de Montréal, Montréal, Québec H2W 1R7, Canada; Department of Medicine, Division of Experimental Medicine, McGill University, Montreal, Québec H4A 3J1, Canada; Department of Medicine, Université de Montréal, Montréal, Québec H3C 3J7, Canada.
Patricia J GearhartLaboratory of Molecular Biology and Immunology, National Institute on Aging, NIH, Baltimore, MD 21224 USA. Electronic address: gearhartp@mail.nih.gov.

Funding

Roles for Transcription in Antibody DiversityZIAAG000714 · NIA · NATIONAL INSTITUTE ON AGING · PI GEARHART, PATRICIA J · 2009 to 2025
$10.9M
Intramural NIH HHS ZIA AG000714
6 · The paper itself

Abstract

Antibody diversity in B cells arises from the activity of activation-induced deaminase (AID), which introduces uracils into DNA of the immunoglobulin loci. The presence of uracil initiates a cascade of mutagenic events, resulting in somatic hypermutation and class switch recombination (CSR). To produce CSR, uracils are removed from DNA by uracil DNA glycosylase (UNG), resulting in formation of an abasic site, which is subsequently transformed into a double-stand break and promotes recombination to another constant gene. While the classical model indicates that B cells are activated when the IgM receptor binds antigen, stimulation of cells ex vivo with anti-IgM is insufficient for CSR. In fact, anti-IgM stimulation has a strong inhibitory effect on CSR when added together with lipopolysaccharide (LPS). To determine the mechanism of anti-IgM inhibition of CSR, we examined the known components required for CSR: AID and UNG. After stimulation with anti-IgM and LPS, AID was expressed and recruited to the immunoglobulin loci, and UNG levels increased and prevented uracil accumulation. We also linked the increased expression of UNG to the cell-cycle, as the presence of anti-IgM allowed cells to enter S-phase sooner. Therefore, for efficient CSR, AID-induced uracils must accumulate to sufficient levels before initiating S-phase, to provide more substrate for UNG and endonuclease to generate mutagenic strand breaks. If cell division occurs too early, as in the case of stimulation with anti-IgM and LPS, UNG is quickly upregulated and removes the uracils before they can accumulate, resulting in faithful DNA repair and less CSR.

Indexed as

DNA RepairImmunoglobulin Class SwitchingReceptors, Antigen, B-CellRecombination, GeneticAICDA (Activation-Induced Cytidine Deaminase)AnimalsB-LymphocytesCytidine DeaminaseImmunoglobulin MLipopolysaccharidesMiceUracilUracil-DNA GlycosidaseAICDA (Activation-Induced Cytidine Deaminase)Cytidine DeaminaseImmunoglobulin MLipopolysaccharidesReceptors, Antigen, B-CellUracilUracil-DNA GlycosidaseActivation-induced deaminaseAnti-IgMB cellsClass switch recombinationUracil DNA glycosylase

Identifiers

PMID41831272
PMCPMC13059788

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.